UnitedHealth Group issues 2025 guidance before investor conference is canceled

UnitedHealth Group issues 2025 guidance before investor conference is canceled

UnitedHealth Group issues 2025 guidance before investor conference is canceled
UnitedHealth Group issues 2025 guidance before investor conference is canceled

On Tuesday, UnitedHealth Group (NYSE:UNH) presented its 2025 outlook ahead of its investor conference on Wednesday, which had to be abruptly cut short. The company’s insurance division, CEO of United Healthcare Brian Thompsonwas fatally shot in what was reportedly a targeted attack.

The healthcare giant expects revenue of $450 billion to $455 billion in 2025, topping the consensus of $431.397 billion.

The forecast includes Optum sales of $277 billion to $280 billion and UnitedHealthcare sales of $337 billion to $340 billion.

Also Read: Big Pharma Pharmacy Benefit Managers Accuse the FTC of Overreach in its Efforts to Transform the Drug Discount System

The company expects net income of $28.15 to $28.65 per share and adjusted net income of $29.50 to $30.00 per share.

According to its October SEC filing, the company expects diluted earnings per share for 2025 to be at the high end of a range of about $28.75. Adjusted net income per share of $30.00 excludes amortization expense of approximately $1.65 per share and related tax impact of $0.40 per share.

Cash flow from operations is expected to be between $32 billion and $33 billion in 2025.

As announced in the third quarter earnings release, UnitedHealth’s 2024 net income is expected to be $15.50 to $15.75 per share and adjusted net income is expected to be $27.50 to $27.75 per share.

For 2025, the company expects a medical coverage ratio of 86.5% ± 50 basis points and an operating expense ratio of 12.5% ​​± 50 basis points.

The company expects the number of consumers served to be 50.97 million to 51.32 million, including 8.4 million to 8.45 million in Medicare Advantage and 7.675 million to 7.775 million in Medicaid.

Last month, the Justice Department sued over UnitedHealth’s $3.3 billion purchase of health services company Amedisys, citing concerns about competition in the home health services market.

UnitedHealth’s Optum unit has launched a website designed to highlight the benefits of the combination. The website notes that despite the growing market, the home healthcare industry remains highly fragmented.

Price promotion: UNH shares were up 2.63% at $621.12 at last check on Wednesday.

Read more:

Image via Shutterstock

UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get the best trading ideas dailyplus unlimited access to cutting-edge tools and strategies to get ahead of the markets.

Get the latest stock analysis from Benzinga?

This article: UnitedHealth Group issues 2025 guidance before halting investor conference originally appeared on Benzinga.com

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Leave a Reply

Your email address will not be published. Required fields are marked *